Outset Medical Q3 revenue $26.3M, up 91% YoY; raises 2021 guidance to $99-101M

Outset Medical, Inc.

2022-Q3 EPS reported -$1.96 revenue$74,450,000

Revenue $26.3M (+91.3% YoY); product revenue $21.8M (+101.9% YoY).
Net loss $30.5M ($0.65 loss per share); non-GAAP net loss $27.6M ($0.59).
Gross margin improved to 11.2% from (37.3%) a year ago; product gross margin turned positive at 5.9%.
FY2021 revenue guidance raised to $99-101M from prior $97-100M.
Received favorable TPNIES decision for Tablo; cash balance $406.4M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.